ERBB2 and breast carcinoma: One study suggested that the level of AR was negatively associated with immune infiltration (M2 tumor-associated macrophages, CD3+ and CD8+ T-cell) in HER2+ metastatic breast cancer22, which was consistent with our results in HER2+ nonmetastatic breast cancer.